169 related articles for article (PubMed ID: 8511991)
1. Immunoassay for urinary pyridinoline: the new marker of bone resorption.
Seyedin SM; Kung VT; Daniloff YN; Hesley RP; Gomez B; Nielsen LA; Rosen HN; Zuk RF
J Bone Miner Res; 1993 May; 8(5):635-41. PubMed ID: 8511991
[TBL] [Abstract][Full Text] [Related]
2. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
Robins SP; Woitge H; Hesley R; Ju J; Seyedin S; Seibel MJ
J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
[TBL] [Abstract][Full Text] [Related]
3. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
Seibel MJ; Woitge H; Scheidt-Nave C; Leidig-Bruckner G; Duncan A; Nicol P; Ziegler R; Robins SP
J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828
[TBL] [Abstract][Full Text] [Related]
4. Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis.
Nur E; Mairuhu W; Biemond BJ; van Zanten AP; Schnog JJ; Brandjes DP; Otten HM;
Am J Hematol; 2010 Nov; 85(11):902-4. PubMed ID: 20882525
[TBL] [Abstract][Full Text] [Related]
5. Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links.
Srivastava AK; Libanati C; Oberrauch W; Leenings J; Greenwald M; Baylink DJ
J Bone Miner Metab; 2003; 21(3):134-44. PubMed ID: 12720047
[TBL] [Abstract][Full Text] [Related]
6. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
Randall AG; Kent GN; Garcia-Webb P; Bhagat CI; Pearce DJ; Gutteridge DH; Prince RL; Stewart G; Stuckey B; Will RK; Retallack RW; Price RI; Ward L
J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
[TBL] [Abstract][Full Text] [Related]
7. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
[TBL] [Abstract][Full Text] [Related]
8. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
9. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis.
Eastell R; Colwell A; Hampton L; Reeve J
J Bone Miner Res; 1997 Jan; 12(1):59-65. PubMed ID: 9240726
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
Papatheofanis FJ
J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144
[TBL] [Abstract][Full Text] [Related]
11. [Urinary excretion of free and total deoxypyridinoline during secondary hyperparathyroidism in the elderly. Comparison of chromatographic (HPLC) and immunoenzymatic (Pyrilinks-D) methods].
Meddah B; Brazier M; Kamel S; Maamer M; Samson L; Desmet G; Sebert JL
Ann Biol Clin (Paris); 1996; 54(10-11):353-8. PubMed ID: 9092303
[TBL] [Abstract][Full Text] [Related]
12. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatography method to analyze free and total urinary pyridinoline and deoxypyridinoline.
Vesper HW; Audain C; Woolfitt A; Ospina M; Barr J; Robins SP; Myers GL
Anal Biochem; 2003 Jul; 318(2):204-11. PubMed ID: 12814623
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of hydroxy-pyridinium cross-links of collagen reflects skeletal growth velocity in normal children.
Rauch F; Schönau E; Woitge H; Remer T; Seibel M
Exp Clin Endocrinol; 1994; 102(2):94-7. PubMed ID: 8056058
[TBL] [Abstract][Full Text] [Related]
15. Markers of bone resorption--measurement in serum, plasma or urine?
Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
[TBL] [Abstract][Full Text] [Related]
16. Diurnal variation in concentrations of various markers of bone metabolism in dogs.
Liesegang A; Reutter R; Sassi ML; Risteli J; Kraenzlin M; Riond JL; Wanner M
Am J Vet Res; 1999 Aug; 60(8):949-53. PubMed ID: 10451203
[TBL] [Abstract][Full Text] [Related]
17. [Determination of bone markers in dairy cows with parturient paresis].
Liesegang A; Eicher R; Kraenzlin M; Rüsch P; Wanner M; Riond JL
Schweiz Arch Tierheilkd; 1998; 140(10):405-11. PubMed ID: 9803160
[TBL] [Abstract][Full Text] [Related]
18. Validation of a high-performance liquid chromatographic assay for lysylpyridinoline in urine: a potential biomarker of bone resorption.
Casserly UM; O'Rorke A; Power MJ; Fottrell PF
Anal Biochem; 1996 Nov; 242(2):255-60. PubMed ID: 8937570
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
Samani KK; Brazier M; Mathiot C; Kamel S; Jamart J; Jaubert J; Blanc M; Azaïs I; Facon T; Leleu X
Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198
[TBL] [Abstract][Full Text] [Related]
20. Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods.
Kamel S; Brazier M; Neri V; Picard C; Samson L; Desmet G; Sebert JL
J Bone Miner Res; 1995 Sep; 10(9):1385-92. PubMed ID: 7502711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]